cell lung cancer nsclc potential cure surgical resection unfortunately NUMBER patients NUMBER present intrathoracic localized disease candidates curative surgical resection elderly patients resectable disease medical contraindications surgery cardiovascular disease pulmonary dysfunction radiation therapy rt lung cancer practiced NUMBER curative thoracic irradiation inoperable unresectable nsclc NUMBER preoperative postoperative irradiation NUMBER thoracic irradiation small cell lung cancersclc NUMBER prophylactic cranial irradiation pci sclc NUMBER palliative irradiation advanced disease recent evidence indicates rt high equivalent doses NUMBER gy using conventional daily fractionation improve survival rate patients locally advanced unresectable nsclc combined chemotherapy administered altered fractionation sclc additions thoracic rt prophylactic cranial irradiation systemic chemotherapy improved disease control patients advanced disease rt provided relief symptoms newer radiotherapeutic methods expected hold promise increasing dose tumor sparing normal tissue recently heavy ion charged particle therapy brachytherapy stereotactic irradiation fractionation shown promise treatment lung cancer furthermore advances technology treatment delivery especially treatment planning systems patient fixation tools respiration synchronous systems rt references NUMBER non small limited stage cisplatin based limited stage multi daily dimensional